Rongkuan Hu is the founder of Starna Therapeutics. Starna Therapeutics has raised $66M in total funding. Latest round: Series B. Based in Suzhou, China.
Rongkuan Hu is the Founder and CEO of Starna Therapeutics, a Suzhou-based biotech company focused on mRNA drugs and in vivo CAR-T programs. He founded the company in 2021 and has led its growth through multiple funding rounds. Hu also serves as an Adjunct Professor.
Full founder directory · Investor directory · Company funding database · Fundraising library